Ohr Pharmaceutical Inc., SKS Ocular LLC deal

Ohr completed the purchase of ophthalmic company SKS Ocular for an upfront payment comprising $3.5 million in cash and 1.2 million Ohr shares, which are valued at $10.2 million based on Ohr's close of...